[1]     Evidence-Based Medicine Working Group.  Evidence-based medicine-a new approach to teaching the practice of medicine[J]. JAMA, 1992, 268(17): 2420-2425.



[2]     Kelly MP， Heath I， Howick J，et al. The importance of values in evidence-based medicine[J]. BMC Med Ethics, 2015, 12;16(1): 69.



[3]     ACOG. Committee on patient safety and quality improvement. Committee Opinion No. 629. Clinical guidelines and standardization of practice to improve outcomes[J]. Obstet Gynecol, 2015, 125(4): 1027-1029. 



[4]    Cantwell R, Clutton-Brock T, Cooper G, et al. Saving mothers’ lives: reviewing maternal deaths to make motherhood safer:  2006–2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom[J]. BJOG, 2011, 118(suppl 1): 1-203.



[5]     American College of Obstetricians and Gynecologists，Task Force on Hypertension in Pregnancy. Hypertension in pregnancy-report of the American College of Obstetricians and    Gynecologists’ Task Force on Hypertension in Pregnancy[J]. Obstet Gynecol, 2013, 122(5): 1122-1131.



[6]    National Collaborating Centre for Women's and Children's Health (UK).  Hypertension in pregnancy: the management of hypertensive disorders during pregnancy[M]. London: RCOG Press, 2010.



[7]    American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 142: cerclage for the management of cervical insufficiency[J]. Obstet Gynecol, 2014, 123(2 Pt 1): 372-379.



[8]     杨孜， 张为远. 妊娠期高血压疾病诊治指南（2015）解读[J]. 中国实用妇科与产科杂志, 2015, 31(10): 886-893.



[9]     ACOG. Committee on Obstetric Practice.  Committee Opinion No. 623: emergent therapy for acute-onset， severe hypertension during pregnancy and the postpartum period[J]. Obstet Gynecol, 2015, 125(2): 521-525.



[10]     Firoz T，Magee LA，MacDonell K，et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review[J]. BJOG, 2014, 121(10): 1210-1218.



[11]     ACOG. Committee Opinion No. 638: first-trimester risk assessment for early-onset preeclampsia[J]. Obstet Gynecol, 2015, 126 (3): e25-27.



[12]     American College of Obstericians and Gynecologists.  ACOG Practice Bulletin. Cervical insufficiency[J]. Obstet Gynecol, 2003, 102(5 Pt 1): 1091-1099.



[13]     Iams JD. Clinical practice. Prevention of preterm parturition[J]. N Engl J Med, 2014, 370(3): 254-261.



[14]     郭艳军，杨孜，刘朝晖, 等. 早期早产临产不同干预措施的探讨[J]. 实用妇产科杂志, 2007, 23(10）：605-607.



[15]     杨孜. 紧急宫颈环扎术在抗早产中的应用价值[J]. 中国妇产科临床杂志, 2008, 9（6）: 405-407.



[16]     祝丽琼，张建平. 紧急宫颈环扎术的指征与注意事项[J]. 中国实用妇科与产科杂志, 2014, 30(2): 108-110.



[17]     Redman CW， Sargent IL.  Immunology of pre-eclampsia[J]. Am J Reprod Immunol, 2010, 63(6): 534-543.



[18]     Quinn KH， Lacoursiere DY， Cui L， et al. The unique pathophysiology of early-onset severe preeclampsia:  role of decidual T regulatory cells[J]. J Reprod Immunol, 2011, 91(1-2): 76-82.



[19]     Cotechini T， Graham CH.  Aberrant maternal inflammation as a cause of pregnancy complications:  a potential therapeutic target?[J]. Placenta, 2015, 36(8): 960-966.



[20]     Block-Abraham DM， Turan OM， Doyle LE， et al.  First trimester maternal characteristics， Doppler parameters， and serum analytes after preeclampsia[J]. Hypertens Pregnancy，2014，33(2): 204-214.



[21]     Ding X， Yang Z， Han Y，et al. Adverse factors increase preeclampsia-like changes in pregnant mice with abnormal lipid metabolism[J]. Chin Med J (Engl), 2014, 127(15): 2814-2818.



[22]     Valentin L. Prediction of scar integrity and vaginal birth after caesarean delivery[J]. Best Pract Res Clin Obstet Gynaecol, 2013, 27(2): 285-295.



（2015-11-06 收稿）